» Articles » PMID: 16191191

Biochemical Characterization of Cdk2-Speedy/Ringo A2

Overview
Journal BMC Biochem
Publisher Biomed Central
Specialty Biochemistry
Date 2005 Sep 30
PMID 16191191
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Normal cell cycle progression requires the precise activation and inactivation of cyclin-dependent protein kinases (CDKs), which consist of a CDK and a cyclin subunit. A novel cell cycle regulator called Speedy/Ringo shows no sequence similarity to cyclins, yet can directly bind to and activate CDKs. Speedy/Ringo proteins, which bind to and activate Cdc2 and Cdk2 in vitro, are required for the G2 to M transition during Xenopus oocyte maturation and for normal S-phase entry in cultured human cells.

Results: We have characterized the substrate specificity and enzymatic activity of human Cdk2-Speedy/Ringo A2 in order to gain insights into the possible functions of this complex. In contrast to Cdk2-cyclin A, which has a well-defined consensus target site ((S/T)PX(K/R)) that strongly favors substrates containing a lysine at the +3 position of substrates, Cdk2-Speedy/Ringo A2 displayed a broad substrate specificity at this position. Consequently, Cdk2-Ringo/Speedy A2 phosphorylated optimal Cdk2 substrates such as histone H1 and a KSPRK peptide poorly, only approximately 0.08% as well as Cdk2-cyclin A, but non-canonical Cdk2 substrates such as a KSPRY peptide relatively well, with an efficiency of approximately 80% compared to Cdk2-cyclin A. Cdk2-Speedy/Ringo A2 also phosphorylated authentic Cdk2 substrates, such as Cdc25 proteins, which contain non-canonical CDK phosphorylation sites, nearly as well as Cdk2-cyclin A. Phosphopeptide mapping indicated that Cdk2-Speedy/Ringo A2 and Cdk2-cyclin A phosphorylate distinct subsets of sites on Cdc25 proteins. Thus, the low activity that Cdk2-Speedy/Ringo A2 displays when assayed on conventional Cdk2 substrates may significantly underestimate the potential physiological importance of Cdk2-Speedy/Ringo A2 in phosphorylating key subsets of Cdk2 substrates. Unlike Cdk2-cyclin A, whose activity depends strongly on activating phosphorylation of Cdk2 on Thr-160, neither the overall catalytic activity nor the substrate recognition by Cdk2-Speedy/Ringo A2 was significantly affected by this phosphorylation. Furthermore, Cdk2-Speedy/Ringo A2 was not a suitable substrate for metazoan CAK (which phosphorylates Cdk2 at Thr-160), supporting the notion that Speedy/Ringo A2 activates Cdk2 in a CAK-independent manner.

Conclusion: There are major differences in substrate preferences between CDK-Speedy/Ringo A2 and Cdk2-cyclin complexes. These differences may accommodate the CAK-independent activation of Cdk2 by Speedy/Ringo A2 and they raise the possibility that CDK-Speedy/Ringo A2 complexes could phosphorylate and regulate a subset of non-canonical CDK substrates, such as Cdc25 protein phosphatases, to control cell cycle progression.

Citing Articles

Atypical cell cycle regulation promotes mammary stem cell expansion during mammary development and tumourigenesis.

Fifield B, Vusich J, Haberfellner E, Andrechek E, Porter L Breast Cancer Res. 2024; 26(1):106.

PMID: 38943151 PMC: 11212383. DOI: 10.1186/s13058-024-01862-1.


A novel function for CDK2 activity at meiotic crossover sites.

Palmer N, Talib S, Singh P, Goh C, Liu K, Schimenti J PLoS Biol. 2020; 18(10):e3000903.

PMID: 33075054 PMC: 7595640. DOI: 10.1371/journal.pbio.3000903.


The atypical cyclin-like protein Spy1 overrides p53-mediated tumour suppression and promotes susceptibility to breast tumourigenesis.

Fifield B, Qemo I, Kirou E, Cardiff R, Porter L Breast Cancer Res. 2019; 21(1):140.

PMID: 31829284 PMC: 6907270. DOI: 10.1186/s13058-019-1211-3.


Diverse roles for CDK-associated activity during spermatogenesis.

Palmer N, Talib S, Kaldis P FEBS Lett. 2019; 593(20):2925-2949.

PMID: 31566717 PMC: 6900092. DOI: 10.1002/1873-3468.13627.


Atypical cyclins: the extended family portrait.

Quandt E, Ribeiro M, Clotet J Cell Mol Life Sci. 2019; 77(2):231-242.

PMID: 31420702 PMC: 6971155. DOI: 10.1007/s00018-019-03262-7.


References
1.
Poon R, Yamashita K, Adamczewski J, Hunt T, Shuttleworth J . The cdc2-related protein p40MO15 is the catalytic subunit of a protein kinase that can activate p33cdk2 and p34cdc2. EMBO J. 1993; 12(8):3123-32. PMC: 413578. DOI: 10.1002/j.1460-2075.1993.tb05981.x. View

2.
MORGAN D . Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol. 1997; 13:261-91. DOI: 10.1146/annurev.cellbio.13.1.261. View

3.
Songyang Z, Blechner S, Hoagland N, Hoekstra M, Piwnica-Worms H, Cantley L . Use of an oriented peptide library to determine the optimal substrates of protein kinases. Curr Biol. 1994; 4(11):973-82. DOI: 10.1016/s0960-9822(00)00221-9. View

4.
Zhu L, Enders G, Lees J, Beijersbergen R, Bernards R, Harlow E . The pRB-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes. EMBO J. 1995; 14(9):1904-13. PMC: 398289. DOI: 10.1002/j.1460-2075.1995.tb07182.x. View

5.
Sherr C, Roberts J . Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 1995; 9(10):1149-63. DOI: 10.1101/gad.9.10.1149. View